Skip to main content

Advertisement

SpringerLink
Log in

Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Prognosis of the patients with pancreatic adenocarcinoma is still poor due to a recurrence, and liver metastasis is a distant metastasis that is foreboded the short survival period.

Methods

Between 1999 and 2005, 68 patients for pancreatic adenocarcinoma underwent a pancreaticoduodenectomy (n = 17), a pylorus-preserving pancreaticoduodenectomy (n = 27), distal pancreatectomy (n = 22), or total pancreatectomy (n = 2) with an extensive lymph node dissection.

Results

A tumor recurrence occurred to 55 patients (13 of the liver, 21 of the local recurrence, 16 of peritoneal dissemination, three of the lymph node, and two of lung). The low tumor grade and female demonstrated a risk factor for a liver metastasis (P = 0.043, P = 0.031). A logistic regression analysis demonstrated female (P = 0.02) and low tumor grade (P = 0.04) as independent risk factors for recurrence with liver metastasis. The median survival time (MST) was 13.6 months, and MST of patients with a liver metastasis as an initial recurrent site was 13.7 months; the liver metastasis as an initial recurrent site has no impact on the MST after pancreatic resection.

Conclusions

We concluded potentially supporting the hypothesis that even patients thought to be at higher risk of liver metastasis may still be given the chance of resection, considering the satisfying survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, Nakao A, Hiraoka T, Hosotani R, Takeda K (2004) Pancreatic cancer registry in Japan. Pancreas 28:219–230

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigel C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130

    Article  PubMed  Google Scholar 

  3. Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, Haglund C (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54:385–387

    Article  PubMed  Google Scholar 

  4. Japan Pancreas Society (2003) The Japanese classification of pancreatic cancer, 2nd edn. Kanehara, Tokyo

    Google Scholar 

  5. Imamura M, Doi R, Imaizumi T, Funakoshi A, Wakasugi H, Sunamura M, Ogata Y, Hishinuma S, Asano T, Aikou T, Hosotani R, Maetani S (2004) A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136:1003–1011

    Article  PubMed  Google Scholar 

  6. Neoptolemos JP, Russell RCG, Bramhall S, Theis B (1997) Low mortality following resection for pancreatic and periampullary tumours in 1,026 patients: UK survey of specialist pancreatic units. Br J Surg 84:1370–1376

    Article  PubMed  CAS  Google Scholar 

  7. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–257

    Article  PubMed  CAS  Google Scholar 

  8. Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, Miyazawa M, Uchiyama K, Yamaue H (2006) Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 244:1–7

    Article  PubMed  Google Scholar 

  9. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dhaene K, Michelassi F, Lymphadenectomy Study Group (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of head of the pancreas: a multicenter, prospective, randomized study. Ann Surg 228:508–517

    Article  PubMed  CAS  Google Scholar 

  10. Wagner M, Redaelli C, Lietz M, Seiler C, Friess H, Büchler MW (2004) Curative resection in the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594

    Article  PubMed  CAS  Google Scholar 

  11. Roder JD, Thorban S, Pantel K, Siewert JR (1999) Micrometastases in bone marrow: prognostic indicators for pancreatic cancer. World J Surg 23:888–891

    Article  PubMed  CAS  Google Scholar 

  12. Vogel I, Kalthoff H, Henne-Bruns D, Kremer B (2002) Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology 2:79–88

    Article  PubMed  Google Scholar 

  13. Yeo CJ, Cameron JL, Sohn TA, Coleman JA, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Comparison of morbidity and mortality and short-term outcome. Ann Surg 229:613–624

    Article  PubMed  CAS  Google Scholar 

  14. Griffin J, Smalley S, Jewell W, Paradelo J, Reymond R, Hassanein R, Evans RG (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56–61

    Article  PubMed  CAS  Google Scholar 

  15. Shimada K, Sakamoto Y, Sano T, Kosuge T (2006) The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 203:345–352

    Article  PubMed  Google Scholar 

  16. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resectoin for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200

    Article  PubMed  CAS  Google Scholar 

  17. Mosca F, Giulianotti P, Balestracci T, Candio G, Pietrabissa A, Sbrana F, Rossi G (1997) Long-term survival in pancreatic cancer: pylorus-preserving versus whipple pancreatoduodenectomy. Surgery 122:553–566

    Article  PubMed  CAS  Google Scholar 

  18. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118–2123

    Article  PubMed  CAS  Google Scholar 

  19. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival a prospective, single-institution experience. Ann Surg 225:621–636

    Article  PubMed  CAS  Google Scholar 

  20. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198:722–731

    Article  PubMed  Google Scholar 

  21. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1211

    Article  PubMed  Google Scholar 

  22. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511–518

    Article  PubMed  Google Scholar 

  23. Yamaue H, Tanimura H, Tsunoda T, Tani M (1991) Chemosensitivity testing with highly purified fresh human tumor cells with the MTT assay. Eur J Cancer 27:1258–1263

    Article  PubMed  CAS  Google Scholar 

  24. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DI, Büchler MW (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

    Article  PubMed  CAS  Google Scholar 

  25. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Zahurak ML, Goodman SN, Doolev WC, Coleman J, Pitt H (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 211:721–723

    Article  Google Scholar 

  26. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006–2010

    Article  Google Scholar 

  27. Beger HG, Gansauge F, Büchler MW, Link KH (1999) Intra-arterial adjuvant chemotherapy after pancreaicoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 23:946–949

    Article  PubMed  CAS  Google Scholar 

  28. Tani M, Kawai M, Terasawa H, Ina S, Hirono S, Uchiyama K, Yamaue H (2006) Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer? J Surg Oncol 93:485–490

    Article  PubMed  Google Scholar 

  29. Yamaue H, Tani M, Onishi H, Kinoshita H, Nakamori M, Yokoyama S, Uchiyama K (2002) Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 25:366–372

    Article  PubMed  Google Scholar 

  30. Ishikawa O, Ohigashi H, Sasaki Y (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168:361–364

    Article  PubMed  CAS  Google Scholar 

  31. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

    Article  PubMed  CAS  Google Scholar 

  32. Meyers MO, Meszoely IM, Hoffman JP, Watson JC, Ross E, Eisenberg BL (2004) Is reporting of recurrence data important in pancreatic cancer. Ann Surg Oncol 11:304–309

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama,, 641–8510, Japan

    Masaji Tani, Manabu Kawai, Motoki Miyazawa, Seiko Hirono, Shinomi Ina, Ryohei Nishioka, Yoichi Fujita, Kazuhisa Uchiyama & Hiroki Yamaue

Authors
  1. Masaji Tani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manabu Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Motoki Miyazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seiko Hirono
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shinomi Ina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ryohei Nishioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoichi Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kazuhisa Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroki Yamaue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroki Yamaue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tani, M., Kawai, M., Miyazawa, M. et al. Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma. Langenbecks Arch Surg 394, 249–253 (2009). https://doi.org/10.1007/s00423-008-0296-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0296-4

Keywords

Search

Navigation